H&K lands DeSalva to head global healthcare

Share this article:
Hill & Knowlton named GCI Group's AnnaMaria DeSalva to head its worldwide healthcare practice.

DeSalva, who was previously worldwide managing director of the healthcare practice at GCI Group, the PR arm of WPP's Grey Global Group, becomes director, worldwide healthcare practice at Hill & Knowlton.

Before joining GCI group, DeSalva spent six years at Bristol-Myers Squibb (BMS), where she coordinated marketing and government relations teams in Europe to drive reimbursement and adoption of anti-cancer treatments, developed corporate affairs strategy for Latin American and Asia Pacific markets, and led strategic planning and health programs at the BMS Foundation.

DeSalva's is the latest in a string of recent high-level moves at the healthcare practices of top PR agencies. She replaces Paul Oestreicher, who left to head the New York office and healthcare practice of Zeno Group. Oestreicher, in turn, replaced Charlotte Wray, who left Zeno Group to launch Mosaic, a new healthcare firm backed by Omnicom's Brodeur Group.

GCI Group has not named a replacement for DeSalva.  

Share this article:

Email Newsletters

More in News

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.

GSK, Novartis, Lilly play musical chairs

GSK, Novartis, Lilly play musical chairs

The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.

Valeant bids $47B for Allergan

Valeant bids $47B for Allergan

The deal would bring Allergan's Botox and Juvederm under the same roof as Restylane.